Alector
Alector develops and commercializes antibody therapeutics for the treatment of cancer and neurodegenerative diseases.
Business Model:
Revenue: $133.2M
Employees: 201-500
Industries / Tags:
Detailed Alector Information
Geographic Data
Address: 131 Oyster Point Blvd
City: South San Francisco
State: CA
Zip: 94080
Country: US
Financial Info
Stage:
series e
Raised Last:
$133M
Raised Total:$195M
Social
Metrics
2,886,459Website Global Rank
5,856Website Monthly Traffic
Twitter Followers
Description
Alector develops and commercializes antibody therapeutics for the treatment of cancer and neurodegenerative diseases.
Contact Phone:
+14152315660
Contact Email:
Alector went public on 2/7/2019 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
2/7/2019
IPO Valuation:
$1B
Ticker Symbol:
ALEC
IPO Price:
$19/share
Amount Raised:
$176M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
